2012 represents a period with robust news flow for emerging immuno-oncology companies
Cancer Immunotherapy to Take Center Stage at ASCO
June 3, 2010 By Leave a Comment
In early April 2010, we published a 150-page industry report titled “Cancer Vaccine Therapies: Failures and Future Opportunities,” which included an overview of the cancer immunotherapy market, interviews with several key opinion leaders, profiles of nearly 40 companies, and a discussion of the scientific, clinical, and commercial considerations for the major industry participants. An executive [...]
Follow MD Becker Partners